CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Common stock	Common stock to be issued	Series B Preferred stock	Additional Paid-in Capital	Accumulated Comprehensive Gain	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2017	3,618,402	262,872	1,000
Beginning balance, amount at Dec. 31, 2017	$ 362	$ 26	$ 10	$ 19,389,888	$ 25,337	$ (25,578,077)	$ (6,162,454)
Common stock issued upon cashless warrant exercises, shares	142,758
Common stock issued upon cashless warrant exercises, amount	$ 14			(14)
Common stock issued upon conversion of convertible debt and accrued interest, shares	110,816
Common stock issued upon conversion of convertible debt and accrued interest, amount	$ 11			122,773			122,784
Common stock to be issued pursuant to Stock Purchase Agreements, shares		77,578
Common stock to be issued pursuant to Stock Purchase Agreements, amount		$ 8		338,448			338,456
Settlement of derivatives				582,806			582,806
Adjust common stock to be issued, shares		(116,013)
Adjust common stock to be issued, amount		$ (12)		12
Common stock issued for services, shares	25,000
Common stock issued for services, amount	$ 3			96,998			97,000
Unrealized (loss) gain on marketable securities					(17,626)		(17,626)
Net loss						1,870,075	1,870,075
Ending balance, shares at Mar. 31, 2018	3,896,975	224,436	1,000
Ending balance, amount at Mar. 31, 2018	$ 390	$ 22	$ 10	20,530,910	7,711	(23,708,002)	(3,168,959)
Beginning balance, shares at Dec. 31, 2018	5,628,475	302,251	1,000
Beginning balance, amount at Dec. 31, 2018	$ 563	$ 30	$ 10	24,047,027	(7,822)	(26,990,355)	(2,950,547)
Common stock issued upon conversion of convertible debt and accrued interest, shares	910,000
Common stock issued upon conversion of convertible debt and accrued interest, amount	$ 91			245,655			245,746
Common stock to be issued pursuant to Stock Purchase Agreements, shares		20,833
Common stock to be issued pursuant to Stock Purchase Agreements, amount		$ 2		14,998			15,000
Settlement of derivatives				585,850			585,850
Unrealized (loss) gain on marketable securities					13,881		13,881
Net loss						(952,374)	(952,374)
Ending balance, shares at Mar. 31, 2019	6,538,475	323,084	1,000
Ending balance, amount at Mar. 31, 2019	$ 654	$ 32	$ 10	$ 24,893,530	$ 6,059	$ (27,942,729)	$ (3,042,444)